The invention relates to a new use of a known Rho kinase inhibitor, fasudil or a fasudil derivative selected from hydroy-fasudil or dimethylfasudil, in the treatment of amyotrophic lateral sclerosis (ALS).
Sustained release oral preparations containing at least one active ingredient selected from the group consisting of fasudil hydrochloride and its hydrate.
Moreover, the use of fasudil in manufacturing medicants for preventing and/or treating diseases related to damages and/or death of neuron.
The invention relates to the use of a pharmaceutical formulation comprising 1-(5-isoquinolinesulfonyl)homopiperazine (FASUDIL) and derivatives thereof in a matrix body and an envelope surrounding the matrix body.
The use of fasudil in the present invention includes the use in manufacturing medicants for inducing the regeneration of adult brain neural stem cells and /or protecting the neurological functions.
Requêtes fréquentes français :1-200, -1k, -2k, -3k, -4k, -5k, -7k, -10k, -20k, -40k, -100k, -200k, -500k, -1000k,
Requêtes fréquentes anglais :1-200, -1k, -2k, -3k, -4k, -5k, -7k, -10k, -20k, -40k, -100k, -200k, -500k, -1000k,
Traduction Translation Traducción Übersetzung Tradução Traduzione Traducere Vertaling Tłumaczenie Mετάφραση Oversættelse Översättning Käännös Aistriúchán Traduzzjoni Prevajanje Vertimas Tõlge Preklad Fordítás Tulkojumi Превод Překlad Prijevod 翻訳 번역 翻译 Перевод